• Skip to primary navigation
  • Skip to main content
AMRA MedicalAMRA Medical

AMRA Medical

Precision for Decision

  • Career
  • Support
  • Contact Us
  • Solutions
    • Clinical Services
    • Research Services
  • Get Set Up
    • Get Set Up
    • Get a Quote
  • Science
    • What We Do
    • How We Do It
    • Why It Matters
    • Our Core Areas
    • Technology
  • News & Events
    • News
    • Events
  • Resources
    • Webinars
    • Publications
    • Whitepapers
    • Media
  • About Us
    • About AMRA
    • Our Team
    • Partners & Investors
  • Career
  • Support
  • Contact Us

Making a Case for Going Beyond the Liver to Include Muscles for NAFLD: A Systematic Review Published

January 12, 2021
  • Facebook
  • Twitter
  • LinkedIn
  • Mail

[Click on the image to view the review summary video]

Experts from Axcella Health, AMRA Medical, and VCU discuss the muscle-liver crosstalk and its role in the pathogenesis and treatment of NAFLD/NASH in Frontiers in Endocrinology.

 

Sweden, Linköping: Tuesday, January 12, 2021 – A perspective review article titled “Harnessing Muscle-Liver Crosstalk to Treat Nonalcoholic Steatohepatitis” was recently published in Frontiers in Endocrinology as part of a special issue of “Non-Alcoholic Steatohepatitis (NASH)—Metabolic Contributors and Therapeutic Targets.” Authored by scientific experts from Axcella Health, AMRA Medical, Linköping University, and Virginia Commonwealth University (VCU), this paper describes the link between muscle composition and chronic liver diseases, including non-alcoholic fatty liver disease (NAFLD). It discusses in depth the scientific basis of underlying factors outside of the liver to treat NAFLD – affecting nearly one-quarter of the world’s adult population.

The report summarizes the current understanding of the association between sarcopenia and NAFLD and outlines the vital role of the muscle–liver axis in the pathogenic cascade of NASH. Furthermore, the authors delineate key mechanisms driving the complex crosstalk between liver and muscle, including metabolic inflexibility and anabolic resistance that collectively impact insulin resistance and systemic inflammation.

To make a case for new NAFLD interventions, the authors leverage extensive clinical evidence linking sarcopenia and muscle composition to NAFLD, such as large meta-analyses linking sarcopenia, high-quality population-based studies, and AMRA’s research involving MRI-based muscle composition profiling of UK Biobank participants. To address NAFLD/NASH’s complex pathogenesis and generate effective treatments, the authors propose exploring interventions that modify muscle mass, muscle fat, and physical function by simultaneously targeting multiple pathways implicated in muscle‒liver crosstalk.

“Muscle wasting appears to be a nearly universal feature in chronic liver disease patients, and while better appreciated in patients with cirrhosis, it is also commonly associated with patients with NASH,” said Dr. Manu Chakravarthy, MD, Ph.D., lead author of the study. He further stated, “Emerging evidence squarely places muscle composition as a key factor impacting outcomes in NAFLD patients, and targeting those dysregulated processes within the liver-muscle axis represents promising therapeutic strategies to address the burden of NAFLD and NASH.”

Learn more by reading the full publication and hearing from three of the authors, Axcella Health’s Dr. Manu Chakravarthy, AMRA Medical’s Dr. Mikael Forsgren, and VCU’s Dr. Mohammad Shadab Siddiqui, in AMRA’s recent webinar.

All posts
  • Facebook
  • Twitter
  • LinkedIn
  • Mail
AMRA Medical
Follow us

About

AMRA offers clinical services and research services to support transformative care and vital decision-making, from clinical research to clinical care.

  • Data Privacy Policy
  • Cookie Policy

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Contact

  • info@amramedical.com
  • +46 (0) 13 16 26 00
  • Contact Our Support

Newsletter

© 2025 AMRA Medical AB
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
AMRA Medical
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}